Atherosclerosis and Hyperlipidemia

Category icon
Coronary Physiology in Diffuse disease

Zsolt Piroth, Hitoshi Matsuo, Evald Høj Christiansen et al

Category icon
APSC Consensus Recommendations on Dyslipidaemia

Natalie Koh, Brian Ference, Stephen J Nicholls, et al

Category icon
Statin Intensity and Cardiac Allograft Vasculopathy

Tracey M Ellimuttil, Kimberly Harrison, Allman T Rollins, et al

Category icon
Land Ahoy! – The Holistic Physiology Approach

Barbara Stähli , Stephan Kische, Tommaso Gori et al

Category icon
The Role of C-reactive Protein in Patient Risk Stratification and Treatment

Ramón Arroyo-Espliguero, María Carmen Viana-Llamas, Alberto Silva-Obregón, et al

Category icon
ACC 2021 Discussion: The STRENGTH Study

Steven E Nissen, Harriette Van Spall

Category icon
Inflammation and Cardiovascular Disease: The Future

Natalie Arnold, Katharina Lechner, Christoph Waldeyer, et al

Category icon
Rheumatoid Arthritis and Atherosclerotic Cardiovascular Disease

Anne Mirjam Kerola, Silvia Rollefstad, Anne Grete Semb,

Category icon
Dyslipidaemia in the Real World

Ricardo Lopez Santi, Felipe Martínez, Adrian Baranchuk, et al

Related Articles

Articles

APSC Consensus Recommendations on Dyslipidaemia

Natalie Koh, Brian Ference, Stephen J Nicholls,

Published:

Citation: European Cardiology Review 2021;16:e54.

Statin Intensity and Cardiac Allograft Vasculopathy

Tracey M Ellimuttil, Kimberly Harrison, Allman T Rollins,

Published:

Citation: Cardiac Failure Review 2021;7:e15.

The Role of C-reactive Protein in Patient Risk Stratification and Treatment

Ramón Arroyo-Espliguero, María Carmen Viana-Llamas, Alberto Silva-Obregón,

Published:

Citation: European Cardiology Review 2021;16:e28.

Inflammation and Cardiovascular Disease: The Future

Natalie Arnold, Katharina Lechner, Christoph Waldeyer,

Published:

Citation: European Cardiology Review 2021;16:e20.